Assyro AI
Biotech Use Cases
BiotechClinical

Clinical Solutions for Biotech

Assyro AI empowers clinical development professionals in biotechnology companies with intelligent regulatory tools. Assyro AI supports clinical development professionals with regulatory intelligence for trial design, IND submissions, and global clinical requirements. Navigate the regulatory landscape confidently from Phase 1 to NDA.

What Clinical Teams Do

  • Designing and executing clinical trials
  • Preparing IND and CTA submissions
  • Ensuring GCP compliance across trial sites
  • Managing clinical data and trial documentation
  • Interacting with health authorities on clinical matters

Challenges in Biotech

  • Understanding country-specific clinical trial requirements
  • Navigating evolving clinical trial regulations post-COVID
  • Managing decentralized trial regulatory considerations
  • A 5-person RA team is handling work that used to require a department of 15
  • First IND prep takes 8-12 weeks because everything is manual and fragmented

How Assyro AI Helps

  • Track clinical trial regulations across global markets
  • Monitor FDA clinical holds and trial suspensions
  • Generate IND and CTA documentation
  • Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
  • Coordinate CRO deliverables in one workspace with version control and traceable handoffs

Key Skills We Support

Clinical trial designGCP complianceIND/CTA preparationProtocol developmentHealth authority interactions

Regulations We Cover

21 CFR Part 600ICH Q5-Q12FDA CBER guidanceEMA ATMPsBiosimilar guidance

Frequently Asked Questions

Assyro AI provides clinical teams with regulatory intelligence on trial requirements, GCP compliance, and IND/CTA submissions. Our AI tracks clinical holds, monitors competitive developments, and helps prepare regulatory documents.

Yes, Assyro AI assists with IND preparation by providing templates, tracking FDA requirements, and helping generate key sections. Our eCTD validator ensures your IND meets technical submission requirements.

Assyro AI tracks clinical trial regulations worldwide including FDA IND requirements, EMA CTA regulations, and country-specific requirements for major markets. We help teams navigate global clinical development.

That's exactly who we built it for. Assyro gives lean biotech teams the leverage to match the output of a 15-person department. One person manages regulatory intelligence, drafting, validation, and tracking that previously required dedicated specialists for each.

Yes. Assyro pulls relevant FDA guidance, precedent decisions, and designation requirements into your workflow so your team can draft BTD requests faster with the right supporting evidence.

Regulatory Context

Clinical teams in Biotech depend on current regulatory intelligence to keep submissions, quality narratives, and inspection responses aligned with health-authority expectations.

21 CFR Part 600ICH Q5-Q12FDA CBER guidance

Common Mistakes

  • Using one-region trial assumptions for multi-jurisdiction submissions.
  • Delayed protocol amendment impact assessment on filing timelines.
  • Insufficient traceability from clinical decisions to regulatory rationale.

Key Regulatory Terms

Relevant Regulatory Intelligence

Related Actions

Other Roles in Biotech

Clinical in Other Industries

Ready to Transform Your Clinical Operations?

See how Assyro AI can accelerate regulatory work for clinical development professionals in biotechnology companies.

Schedule a Demo